Common genetic variants and risk for non-Hodgkin lymphoma and adult T-cell lymphoma/leukemia in Jamaica

International Journal of Cancer

Volumn 125, Issue 6, 2009, Pages 1479-1482

  Wang, Sophia S ^a   Carreon, J Daniel ^a   Hanchard, Barrie ^b   Chanock, Stephen ^a   Hisada, Michie ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF THE WEST INDIES   (Jamaica)

^c TAKEDA PHARMACEUTICALS   (United States)

Author keywords

ATL; HTLV I; Jamaica; NHL; SNP

Indexed keywords

INTERLEUKIN 13; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; GROUPS BY AGE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; JAMAICA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; T CELL LEUKEMIA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERLEUKIN-13; INTERLEUKIN-5; JAMAICA; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR CELL ADHESION MOLECULE-1; YOUNG ADULT;

EID: 68249150598     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24489     Document Type: Article

References (17)

1. IARC. Human immunodeficiency viruses and human T-cell lymphotropic viruses. IARC Monograph on the evaluation of carcinogenic risks to humans 1996. 2008;67:261-424.
2. Manns A, Cleghorn FR, Falk RT, Hanchard B, Jaffe ES, Bartholomew C, Hartge P, Benichou J, Blattner WA. Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago. The HTLV Lymphoma Study Group. Lancet 1993;342: 1447-50.
3. Hisada M, Stuver SO, Okayama A, Li HC, Sawada T, Hanchard B, Mueller NE. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. J Infect Dis 2004;190:1605-9.
4. Goedert JJ, Li HC, Gao XJ, Chatterjee N, Sonoda S, Biggar RJ, Cranston B, Kim N, Carrington M, Morgan O, Hanchard B, Hisada M. Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types. Int J Cancer 2007;121:1092-7.
5. Tsukasaki K, Miller CW, Kubota T, Takeuchi S, Fujimoto T, Ikeda S, Tomonaga M, Koeffler HP. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res 2001;61:3770-4.
6. Choi YL, Tsukasaki K, O'Neill MC, Yamada Y, Onimaru Y, Matsumoto K, Ohashi J, Yamashita Y, Tsutsumi S, Kaneda R, Takada S, Aburatani H, et al. A genomic analysis of adult T-cell leukemia. Oncogene 2007;26:1245-55.
7. Farre L, Bittencourt AL, Silva-Santos G, Almeida A, Silva AC, Decanine D, Soares GM, Alcantara LC, Jr., Van DS, Galvao-Castro B, Vandamme AM, Van WJ. Fas 670 promoter polymorphism is associated to susceptibility, clinical presentation, and survival in adult T cell leukemia. J Leukoc Biol 2008;83:220-2.
8. Maeda T, Yamada Y, Moriuchi R, Sugahara K, Tsuruda K, Joh T, Atogami S, Tsukasaki K, Tomonaga M, Kamihira S. Fas gene mutation in the progression of adult T cell leukemia. J Exp Med 1999;189:1063-71.
9. Takeuchi S, Matsushita M, Tsukasaki K, Takeuchi N, Tomonaga M, Komatsu N, Ikezoe T, Uehara Y, Koeffler HP. P53 codon 72 polymorphism is associated with disease progression in adult T-cell leukaemia/ lymphoma. Br J Haematol 2005;131:552-3.
10. VanVeldhuisen PC, Walters M, Sawada T, Levine PH, Wilks R, Hanchard B, Hisada M. Seroincidence of human T-lymphotropic virus type I infection and characterization of seroconverters in Jamaican food handlers. J Acquir Immune Defic Syndr 2003;33:387-92.
11. Excoffier L, Slatkin M Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995;12:921-7.
12. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-34.
13. Nagakubo D, Jin Z, Hieshima K, Nakayama T, Shirakawa AK, Tanaka Y, Hasegawa H, Hayashi T, Tsukasaki K, Yamada Y, Yoshie O. Expression of CCR9 in HTLV-11 T cells and ATL cells expressing Tax. Int J Cancer 2007;120:1591-7.
14. Ishikawa T, Imura A, Tanaka K, Shirane H, Okuma M, Uchiyama T. E-selectin and vascular cell adhesion molecule-1 mediate adult T-cell leukemia cell adhesion to endothelial cells. Blood 1993;82:1590-8.
15. Sanda T, Asamitsu K, Ogura H, Iida S, Utsunomiya A, Ueda R, Okamoto T. Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor. Leukemia 2006;20:590-8.
16. Takeuchi S, Takeuchi N, Tsukasaki K, Yang Y, Fermin AC, Tomonaga M, Miller CW, Seo H, Koeffler HP. Methylenetetrahydrofolate reductase genotype does not play a role in adult T-cell leukemia/ lymphoma pathogenesis among human T-lymphotrophic virus type 1 carriers. Leuk Res 2004;28:1039-41.
17. Hisada M, Stuver SO, Okayama A, Li HC, Sawada T, Hanchard B, Mueller NE. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. J Infect Dis 2004;190:1605-9.